hotspot -WSS

hotspot

author：fashion 2025-09-27 16:17:03 - browse：62

Powdered ibogaine against a white background. — Tabernanthe iboga, the shrub that contains the psychedelic substance ibogaine. Wikimedia Commons

The psychedelic ibogaine is unlikely to ever receive approval as a treatment for opioid addiction, the federal government’s top addiction researcher said Thursday.

The remarks from Nora Volkow, the longtime director of the National Institute on Drug Abuse, serve as a cautionary note amid widespread enthusiasm about ibogaine, a naturally occurring substance that drug companies and researchers have increasingly cast as a potential paradigm-shifting addiction treatment.

But its potential cardiac side effects could stand in the way of receiving approval from the Food and Drug Administration, Volkow said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Readout Newsletter: Cardior, Regeneron, Nuvation, Dyne and more

knowledge

leisure time

WSS

Apellis safety probe of eye disease drug centers on injection needle

How to make Best Hospitals ratings actually useful for patients

Complete sequence of Y chromosome published for first time

Covid vaccine financial winners and losers, from Pfizer to Novavax

Scientists boost immune system in aging mice by making it youthful

How Long Island became the ‘eugenics capital of the world’

leisure time

hotspot

explore

United colonoscopy coverage change 'may cost lives,' doctors say

How to make AI work for medicine

At least 13 dead in Texas as scorching temps continue

Departing Stanford president retracts two papers

Novavax promises a turnaround & Lilly roils the obesity market

Diversity in medical illustrations gets boost from Chidiebere Ibe

Medical records are filled with copy

Steward Health Care has deal to sell doctor network to UnitedHealth

Moonlake's readout produced a cash windfall. Risks remain

Eliminate the waiting period for sterilization covered by Medicaid

entertainment

Steward Health Care has deal to sell doctor network to UnitedHealth

Study says nonprofit hospitals fall short in charity care spending

Scientists boost immune system in aging mice by making it youthful

Primary care physicians play key roles in Alzheimer's management

AstraZeneca challenges Medicare drug negotiation program

Radiation, mainstay of cancer treatment, begins a fade

knowledge

leisure time

explore

focus